🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a single-arm, open-label study, which will examine the effect of se...
Status
Completed
Location
UCSF Psoriasis and Skin Treatment Center
Start Date
2016-10
Trial ID
NCT02592018
Treatments Being Tested
The purpose of this study is to further evaluate the safety of infliximab, ...
Status
Active Not Recruiting
Location
Multiple Locations
Start Date
2007-06-21
Trial ID
NCT00508547
The primary objective of this non-interventional study is to describe the e...
Status
Active Not Recruiting
Location
Novartis Investigative Site
Start Date
2024-06-17
Trial ID
NCT06444087
Treatments Being Tested
Evaluate the safety, tolerability and pharmacokinetics of AIN457 when admin...
Status
Completed
Location
Novartis Investigative Site
Start Date
2009-03
Trial ID
NCT00809159
This is a randomized, open-label, controlled Phase I study of BR201 adminis...
Status
Completed
Location
The Affiliated Hospital of Qingdao University
Start Date
2024-02-21
Trial ID
NCT06126718
Treatments Being Tested
This is a prospective, randomized, open-label, parallel-controlled clinical...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-07-15
Trial ID
NCT07704190
Treatments Being Tested
The purpose of this study was to provide up to 52 weeks of efficacy, safety...
Status
Completed
Location
Novartis Investigative Site
Start Date
2020-01-29
Trial ID
NCT04209205
Treatments Being Tested
Multicenter, non-interventional, cohort study in pediatric patients with mo...
Status
Active Not Recruiting
Location
Novartis Investigative Site
Start Date
2023-12-29
Trial ID
NCT06142357
Treatments Being Tested
A prospective, controlled, open trial in psoriasis patients with metabolic ...
Status
Unknown
Location
University of Verona
Start Date
2020-08-01
Trial ID
NCT04469829
Treatments Being Tested
This was a randomized, double-blind, active controlled, multicenter, parall...
Status
Completed
Location
Novartis Investigative Site
Start Date
2017-04-03
Trial ID
NCT02745080
Treatments Being Tested